Skip to main content

Table 1 Demographics of TA-TAVI hospital-acquired infections

From: Surgical site infections following transcatheter apical aortic valve implantation: incidence and management

Patient

Sex

Age

LV%

KG/BMI

Co-morbidity

ES

Complications

1. AB

F

79

65

66/33

TIA

23

Pneumothorax

     

Hypothyroidism

 

UTI

     

Previous CABG

 

CK-MB: 32.4

     

Cr cl: 31.0

  

2. JGC

M

79

50

78/27

AF/COPD

26

AF, renal failure,

     

PVD

 

heart failure, pneumonia, empyema CK-MB: 33.4

     

Gout

  
     

RA/steroids

  
     

History DVT Previous CABG

  
     

Cr cl: 31.8

  

3. IR

F

76

65

72/30

Hypothyroidism

23

AF/Flutter

     

Previous DVT/PE

 

CK-MB: 18.8

     

Porcelain aorta

  
     

Cr cl: 61.8

  

4.MB

F

64

50

92.5/35.2

DM/MI

26

Heart failure

     

Pulmonary emboli

 

CK-MB: 12.4

     

Lung Ca/Rorx

  
     

Cr cl: 69.4

  

5. CR

F

77

20

82/31.2

PAF/PVD

26

Heart failure

     

Hypothyroidism

 

CK-MB : 12.4

     

Active smoker

  
     

COPD

  
     

Heart failure

  
     

Cr cl: 26.5

  
  1. AF Atrial fibrillation, CA cancer; CABG; Coronary artery bypass grafting; Cr cl, Creatinine (clearance ml/min); COPD Chronic obstructive pulmonary disease; DVT Deep venous thrombosis; DM Diabetes mellitus; MI Myocardial infarction; PAF, Paroxysmal AF; PE Pulmonary emboli; RA Rheumatoid arthritis; RoRX radiotherapy.